| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/14/2005 | US20050080045 topical administration; prevention of STDs preferably a viral disease other than HIV, e.g. HPV or genital herpes and especially acyclovir resistant genital herpes |
| 04/14/2005 | US20050080041 Method and composition for the treatment of adenoviral ocular infections |
| 04/14/2005 | US20050080018 In particular, use of propionyl-L-carnitine in combination with one or more known useful drugs for preparing medicine for treatment of erectile dysfunction in patients suffering from diabetes mellitus, wherein patients do not respond to treatment with other useful drugs |
| 04/14/2005 | US20050079575 Human receptor molecules |
| 04/14/2005 | US20050079503 Peptide comprising zinc binding of ubiquination protein for use as tool in identifying modulators for treatment and prevention of inflammation, reproductive and cell proliferation disorders |
| 04/14/2005 | US20050079217 Tablet with protective coatings; Parkinson's disease; sexual disorders |
| 04/14/2005 | US20050079156 Method of treating endometreosis |
| 04/14/2005 | US20050079148 Biocompatible polymer designed to release nitric oxide; extensively cross-linked polyamine-derivatized divinylbenzene; sustained release, potentiation |
| 04/14/2005 | US20050076916 Condom |
| 04/14/2005 | CA2540697A1 Extended triphasic contraceptive regimens |
| 04/14/2005 | CA2527617A1 Benzo-(4,5)-thieno-(2,3d)-pyrimidin-4-ones and their use in the treatment or prevention of a steroid hormone dependent disease or disorder |
| 04/13/2005 | EP1522583A2 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sina) |
| 04/13/2005 | EP1522306A1 A pharmaceutical product for hormone replacement therapy comprising tibolone or a derivative thereof and estradiol or a derivative thereof |
| 04/13/2005 | EP1521845A1 Method for detecting increased susceptibility to tumours |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521768A2 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1294739B1 16,17-carbocyclic condensed steroid compounds having selective estrogenic activity |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1212052B1 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 04/13/2005 | CN1606557A Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606553A Oxytocin agonistenoxytocin agonisten |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606443A Substituted diketopiperazines as oxytocin antagonists |
| 04/13/2005 | CN1605354A Yang strengthening capsule and its preparation |
| 04/13/2005 | CN1605352A Plaster for treating hyperplasia of mammary glands |
| 04/13/2005 | CN1605337A Application of cnidium fruit element in the preparing process of medicine for preventing and treating Sexual dysfunction |
| 04/13/2005 | CN1605332A Fibrauretine injection for perfusion and its preparing process |
| 04/13/2005 | CN1196680C Modulators of dopamine neurotransmission |
| 04/13/2005 | CN1196493C Medicines for treating sterility |
| 04/13/2005 | CN1196487C 单位剂量形式 The unit dosage form |
| 04/13/2005 | CN1196483C Compositions for improivng fertility |
| 04/12/2005 | US6878750 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878721 Beta2-adrenoceptor agonists |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878708 Imidazotriazinones and the use thereof |
| 04/12/2005 | US6878701 Potassium channel blocking agents |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | CA2385854C Formulation for menopausal women |
| 04/12/2005 | CA2356065C Phenoxyphenylheterocycle derivatives as ssris |
| 04/12/2005 | CA2194471C Bis-piperidinyl non-peptidyl tachykinin receptor antagonist |
| 04/07/2005 | WO2005030803A1 Therapeutic molecules |
| 04/07/2005 | WO2005030754A1 Indole or quinoline derivatives as non-pepticid npy y2 receptor inhibitors useful for the treatment of anxiolytic and depressive disorders and obesity |
| 04/07/2005 | WO2005030148A2 Tetrahydroindolone derivatives for treatment of neurological conditions |
| 04/07/2005 | WO2005018657A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 04/07/2005 | WO2004006847A3 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 04/07/2005 | US20050075396 Modulation of type 2 diabetes and drug delivery |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075373 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/07/2005 | US20050075351 4-(Azaindol-3-yl)-quinazoline, 4-(azaoxindol-3-yl)-quinazoline, or 4-(diazaindol-3-yl)-quinazoline derivatives as glycogen synthase kinase inhibitors; Alzheimer's, Parkinson's, Huntington's disease; Down syndrome, amyotrophic lateral sclerosis; neurodegenerative and brain disorders; cognition activators |
| 04/07/2005 | US20050075349 Xanthine phosphodiesterase V inhibitors |
| 04/07/2005 | US20050075344 Melanocortin receptor agonists |
| 04/07/2005 | US20050075339 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 04/07/2005 | US20050075322 Androgenic 7-substituted 11-halogen steroids |
| 04/07/2005 | US20050075315 Antitumor agent |
| 04/07/2005 | US20050075314 Using pharmaceutical preparation of mucopolysaccharides having an anticoagulant activity of <100 BP units/mg for prophylactic priming or curative treatment of the cervix and the myometrium; sulfates of heparin chondroitin and dermatan and their depolymerized products |
| 04/07/2005 | US20050075284 peptide analogues or conjugates of vasoactive intestinal peptide(VIP), used for vaginal relaxation and/or for modulation of sperm motility |
| 04/07/2005 | US20050075273 condensation aerosols; for treatment of pain or alcohol abuse; kits |
| 04/07/2005 | US20050075271 Crystalline beta2 adrenergic receptor agonist |
| 04/07/2005 | US20050075269 Substituted benzofuran-2-carboxamides derivatives |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | DE10341923A1 Verwendung von Tolperison Use of Tolperisone |
| 04/07/2005 | CA2580730A1 Tetrahydroindolone derivatives for treatment of neurological conditions |
| 04/06/2005 | EP1520856A1 Androgen receptor agonist |
| 04/06/2005 | EP1520855A1 Thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 04/06/2005 | EP1520583A2 NKT cell-activating agents containing alpha-glycosylceramides |
| 04/06/2005 | EP1519943A2 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 04/06/2005 | EP1519920A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP1519746A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 04/06/2005 | EP1519733A1 Compositions for cancer therapy comprising saponins or sapogenins |
| 04/06/2005 | EP1519730A1 Novel use of imidazotriazinones |
| 04/06/2005 | EP1519726A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 04/06/2005 | EP1519720A2 Novel formate salt of o-desmethyl-venlafaxine |
| 04/06/2005 | EP1040190B1 Serine proteinase inhibitors |
| 04/06/2005 | EP1006964B1 Intrauterine chemical necrosing compositions and apparatus |
| 04/06/2005 | EP0912521B1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604900A 6-aminomorphinane derivatives, method for production and use thereof |
| 04/06/2005 | CN1604772A Transdermal transport of compounds |
| 04/06/2005 | CN1602950A Pharmaceutical composition for treating climacteric syndrome and its preparing process |
| 04/06/2005 | CN1602941A Chinese medicinal formulation for treating pelvic inflammation with improved bioavailability and drug effect and preparation process thereof |
| 04/06/2005 | CN1602937A Beautifying and climacteric syndrome treating composition, its preparing process and usage |
| 04/06/2005 | CN1602914A Tumor eliminating powder |
| 04/06/2005 | CN1602913A Pelvic inflammation treating traditional Chinese medicinal preparation |
| 04/06/2005 | CN1602864A Vaginal effervescent tablet of fibrauretine and its preparation method |
| 04/06/2005 | CN1602858A Arteannuin preparation for treating gynecopathy |
| 04/06/2005 | CN1602852A Sodium houttuyfonate injection and its preparation method |
| 04/06/2005 | CN1195545C Vaginal suppository vaccine for urogenital infections |
| 04/06/2005 | CN1195532C Oral capsule for treating condyloma acuminata |
| 04/06/2005 | CN1195523C Topical compositions for prostaglandin E1 delivery |
| 04/06/2005 | CN1195506C Transdermal therapeutic system with improved stability and method for production thereof |
| 04/06/2005 | CN1195503C Transdermal patch and topical compositions comprising propylnorapomorphine |
| 04/05/2005 | US6875886 Modified PSMA ligands and uses related thereto |
| 04/05/2005 | US6875846 Heterologous polypeptide of the TNF family |